Clinical Trial Update: A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of SPM 962 for advanced Parkinson's disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SPM 962

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-03-19